Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs and Organics Limited has submitted its quarterly Reconciliation of Share Capital Audit Report to the stock exchanges as required under SEBI (Depositories and Participants) Regulations, 2018. The report covers the quarter ended March 31, 2025 and was certified by Ragini Chokshi & Co., Company Secretaries. The company's issued and listed capital stands at 1,58,28,248 shares of Rs. 10 face value each, with 36.68% held in CDSL and 63.32% in NSDL, and just 10 shares in physical form. There were no changes in share capital during the quarter, no pending dematerialisation requests beyond 21 days, and the Register of Members is fully updated.
This is a routine quarterly compliance filing with no change in share capital or material corporate action. It is unlikely to have any meaningful impact on the stock price or shareholder value, as the report simply confirms that the company's share capital records are in order.